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Abstract
Two common concerns raised in analyses of randomized experiments are (i) appropriately
handling issues of non-compliance, and (ii) appropriately adjusting for multiple tests (e.g., on
multiple outcomes or subgroups). Although simple intention-to-treat (ITT) and Bonferroni
methods are valid in terms of type I error, they can each lead to a substantial loss of power;
when employing both simultaneously, the total loss may be severe. Alternatives exist to address
each concern. Here we propose an analysis method for experiments involving both features
that merges posterior predictive p-values for complier causal effects with randomization-based
multiple comparisons adjustments; the results are valid familywise tests that are doubly ad-
vantageous: more powerful than both those based on standard ITT statistics and those using
traditional multiple comparison adjustments. The operating characteristics and advantages of
our method are demonstrated through a series of simulated experiments and an analysis of the
United States Job Training Partnership Act (JTPA) Study, where our methods lead to different
conclusions regarding the significance of estimated JTPA effects.
Keywords: Causal inference; hypothesis testing; multiple comparisons; posterior predictive p-
value; principal stratification; randomization-based inference.
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1 Introduction
The United States Job Training Partnership Act (JTPA) Study was a randomized experiment in the
1980s designed to measure the effects of a national, publicly-funded training program. Participants
randomly assigned to the treatment group were eligible to receive JTPA services, while participants
randomly assigned to the control group were barred from JTPA services for 18 months. Only about
2/3 of the treatment participants, however, actually enrolled and received any JTPA services; the
other 1/3 failed to comply with their treatment assignment. Furthermore, because of the fluid
nature of the participants’ employment, researchers were interested in measuring JTPA effects
across several time periods after random assignment, including the in-training period and the
first and second post-program years. Analyzing such data requires addressing two substantial
concerns: (i) due to non-compliance, the effects of treatment assignment are not equivalent to the
effects of treatment receipt, and (ii) conducting tests for multiple time periods without appropriate
adjustments may lead to an inflated type I error rate. In this paper, we outline an analysis method
that addresses both concerns while maintaining reasonable power to detect treatment effects.
When units in randomized experiments fail to comply with their random assignment, inference
for the effects of treatment receipt, rather than of assignment alone, becomes less straightforward.
Intention-to-treat (ITT) analyses, which ignore treatment receipt, may have low power when as-
signment alone has no effect on the experimental outcome. In order to address this loss of power,
Rubin (1998) introduced randomization-based posterior predictive p-values for the complier average
causal effect (CACE) and showed through simulation that (i) they are valid p-values in terms of
type I error, and (ii) their tests have higher power than tests using ITT p-values under reasonable
alternative hypotheses (e.g., hypotheses with non-zero treatment effects for units who are assigned
to and receive treatment, but zero treatment effects for units who do not receive it). This frame-
work follows the general approach for Bayesian causal inference in randomized experiments with
non-compliance outlined by Imbens and Rubin (1997). Both pieces of work rely on the multiple
imputation (Rubin, 1987) of missing compliance statuses; separating the experimental units into
principal strata (Frangakis and Rubin, 2002) based on compliance behavior aids inference for the
desired causal effect. We use these tools in our approach but adapt them for simultaneous testing
of multiple outcomes and subgroups.
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Multiple testing issues are common in randomized experiments because multiple outcomes and
subgroups of interest are often measured and analyzed for possible effects. Traditionally, practition-
ers have applied Bonferroni corrections to sets of p-values in order to control their familywise error
rate (FWER), i.e., the rate at which at least one type I error is made, in a straightforward manner.
Bonferroni corrections, however, tend to be overly conservative, especially when those p-values are
correlated (Westfall and Young, 1989). This fact has led many applied researchers to avoid Bon-
ferroni corrections and abandon multiple comparisons adjustments altogether (Cabin and Mitchell,
2000; Nakagawa, 2004; Perneger, 1998; Rothman, 1990). Other avenues exist; randomization-based
procedures can provide greater power while maintaining the FWER by accounting for correlated
tests. Brown and Fears (1981) and Westfall and Young (1989) first introduced permutation-based
multiple testing adjustments, though they did not explicitly motivate them using randomized as-
signment mechanisms. Randomization-based procedures are additionally appealing because they
do not require any assumptions about the underlying distribution (here, joint) of the data. Further-
more, recent increases in computational power have helped such procedures become more tractable
and gain popularity (Good, 2005).
In this article, we connect methodological ideas to appropriately handle both non-compliance
and multiple testing in randomized experiments. We build up to this combined approach in stages.
In Section 2, we elucidate the method proposed by Rubin (1998) for evaluating meaningful causal
effects in the presence of non-compliance. In Section 3, we extend the ideas of Westfall and Young
(1989) to fully randomization-based multiple comparisons adjustments and propose such adjust-
ments as a straightforward yet more powerful alternative to Bonferroni corrections. In Section 4,
we merge the notions of non-compliance and multiple testing, and outline a combined method of
analysis that demonstrates power advantages from both perspectives. In each of Sections 2–4, we
empirically show the benefits of the described methods through a series of simulated experiments.
In Section 5, we apply traditional methods and our combined method to JTPA data to evaluate
the program’s effects on employment rate by time period. We illustrate how the methods lead to
different conclusions regarding the significance of estimated JTPA effects. Section 6 concludes.
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2 Experiments with Non-compliance
2.1 Non-compliance as a missing data problem
Suppose we have a randomized experiment with N units, indexed by i, with observed covariates
Xi, randomly assigned to control or active treatment. Let Zi be a binary indicator for assignment
to active treatment, and let Di(z) be a binary indicator for receipt of active treatment under as-
signment z. A unit’s compliance behavior Ci is defined by the pair of potential outcomes (Neyman,
1923; Rubin, 1974) (Di(0), Di(1)); this notation is adequate under the stable unit treatment value
assumption (Rubin, 1980, 1986), which asserts no interference between experimental units, as well
as two well-defined outcomes. Each unit then belongs to one of four possible compliance strata:
• Compliers (Ci = c), who receive their treatment assignment: (Di(0), Di(1)) = (0, 1).
• Never-takers (Ci = nt), who never receive the active treatment: (Di(0), Di(1)) = (0, 0).
• Always-takers (Ci = at), who always receive the active treatment: (Di(0), Di(1)) = (1, 1).
• Defiers (Ci = d), who receive the opposite of their treatment assignment: (Di(0), Di(1)) = (1, 0).
If non-compliance is one-sided — i.e., units assigned to control are prohibited from receiving
the active treatment — then Di(0) = 0 for all i. In such settings, always-takers and defiers do not
exist, and two possible strata are left: compliers and never-takers. Real-world scenarios involving
one-sided non-compliance include many clinical trials, in which new drugs are unavailable to control
patients, and some job training experiments, in which training programs and additional services
are unavailable to the control group.
In many practical settings, researchers are most interested in the compliers because the effect
of treatment assignment is synonymous with the effect of treatment receipt for those units. Strata
membership, however, can never be fully determined for all units because they depend on the two
potential outcomes of D, one of which is missing (i.e., unobserved). Membership can, on the other
hand, be partially determined based on the observed potential outcome, Dobsi . Table 1 outlines the
possible compliance strata based on units’ observed treatment assignment and receipt. An example
“Science” table (Rubin, 2005) under one-sided non-compliance and its observed values under a
particular assignment are shown in Table 2.
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Assignment Receipt Possible Ci Values
Zi D
obs
i One-sided Non-compliance Two-sided Non-compliance
0 0 c, nt c, nt
0 1 – at, d
1 0 nt nt, d
1 1 c c, at
Table 1: Units’ possible compliance strata based on observed treatment assignment and receipt.
D(z) Compliance Y (z) Assignment D(z) Compliance Y (z)
Unit Xi Di(0) Di(1) Ci Y (0) Y (1) Zi Di(0) Di(1) Ci Yi(0) Yi(1)
1 X1 0 0 nt Y1(0) Y1(1) 0 0 ? ? Y
obs
1 ?
2 X2 0 1 c Y2(0) Y2(1) 1 0 1 c ? Y
obs
2
3 X3 0 1 c Y3(0) Y3(1) 1 0 1 c ? Y
obs
3
4 X4 0 0 nt Y4(0) Y4(1) 1 0 0 nt ? Y
obs
4
. . . . . . . . .
N XN 0 1 c YN (0) YN (1) 0 0 ? ? Y
obs
N ?
Table 2: An example Science table under one-sided non-compliance (left) and its corresponding
observed and unobserved values under a particular assignment (right).
Because strata memberships are not fully observed, uncertainty with respect to complier-specific
effects stems from the missing compliance statuses (i.e., D potential outcomes) in addition to the
missing Y potential outcomes. One approach to handling the additional uncertainty is to, in
a Bayesian framework, view the missing compliance statuses as random variables. By multiply
imputing the missing compliance statuses, e.g., according to a distributional model, they can be
integrated out, and we can make inference specific to the compliers.
2.2 Randomization-based posterior predictive p-values
As described by Meng (1994), a posterior predictive p-value can be viewed as the posterior mean
of a classical p-value, averaging over the posterior distribution of nuisance factors (e.g., missing
compliance statuses) under the null hypothesis. Rubin (1998) introduced a randomization-based
procedure, which we expound on here, for obtaining posterior predictive p-values for estimated
complier-only effects. One posterior predictive p-value is the average of many p-values calcu-
lated from multiple “compliance-complete” datasets with imputed compliance statuses; for each
compliance-complete dataset, the p-value is obtained through a randomization test (Fisher, 1925,
1935).
Within one randomization test, however, calculations of the test statistic do not use all of the
compliance information from the compliance-complete data; rather, they use only the compliance
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information that would have actually been observed under particular hypothetical randomizations.
Though implied, this step of re-observing the data is not explicitly stated by Rubin (1998); we
place it in Step 5 of the procedure below for emphasis because it is an important prerequisite
for conducting a proper test. Unlike discrepancy variables (Meng, 1994), which may depend on
unobserved factors (e.g., missing compliance statuses), test statistics must be functions of only the
observed data. In order to conduct a proper test, the true observed test statistic value must be
measured against the correct distribution, i.e., the distribution of that same test statistic.
In this section, we assume a single outcome for simplicity. The procedure for obtaining a
randomization-based posterior predictive p-value is as follows:
1. Choose a test statistic and calculate its observed value.
Choose a test statistic, T , to estimate an effect on the outcome, Y . Examples include the
maximum-likelihood estimate (MLE) of CACE or the posterior median of CACE, given the ob-
served compliance statuses and potential outcomes, under the exclusion restriction (see Angrist,
Imbens, and Rubin, 1996; Imbens and Rubin, 1997). Calculate T on the observed data to obtain
T obs.
for m : 1 to M do
2. Impute missing compliance statuses.
Impute the missing compliance statuses, drawing once from their posterior predictive dis-
tribution according to a compliance model that assumes the null hypothesis (e.g., of zero
effect).
3. Impute missing potential outcomes.
Impute the missing Y potential outcomes under the sharp null hypothesis. Under the typical
sharp null hypothesis of zero treatment effect, the missing potential outcome for unit i is
imputed exactly as Y obsi .
4. Draw a random hypothetical assignment.
Draw a random hypothetical assignment vector according to the assignment mechanism used
in the original experiment.
5. Re-observe the data.
Treating the imputed compliance statuses, imputed potential outcomes, and hypothetical
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assignment vector from Steps 2–4 as true, create a corresponding hypothetical observed dataset
by masking the potential outcomes and compliance statuses that would not have been observed
under the hypothetical assignment.
6. Calculate the test statistic on these data.
Calculate T on the hypothetical observed data to obtain T hyp. Record whether this statistic
is at least as extreme as T obs.
end for
7. Calculate the posterior predictive p-value.
The posterior predictive p-value for the null hypothesis with respect to T equals the proportion
of the M imputation-randomization sets for which T hyp is as extreme as or more extreme than
T obs.
Rubin (1998) discusses several commonly used statistics for evaluating complier causal effects,
only some of which tend to estimate the CACE and thus provide suitable power against appropriate
alternative hypotheses. As is commonly done in the non-compliance literature, we assume the
exclusion restriction (i.e., we assume that treatment assignment has no effect on the outcomes
of never-takers and always-takers) for test statistic calculations throughout this paper. Such an
assumption is not necessary and does not affect the validity of the randomization test, but it does
facilitate more precise estimation of CACE when true (see Imbens and Rubin, 1997) and is often
reasonable.
The imputation in Step 2 is performed probabilistically, using the missing statuses’ null posterior
predictive distribution, given X,Z,Dobs, and Y obs. (Some test statistics, such as the posterior
median of CACE, may be computed by multiply imputing the missing compliance statuses. This
would be a separate imputation from the one described in Step 2 above. If the test statistic
calculation itself involves imputation, such imputation does not need to, and usually does not,
assume the null hypothesis.) The repetition of Steps 2–6 is intended to reflect the uncertainty of
estimation resulting from the missing compliance statuses; M is a large number (e.g., 10, 000) that
controls the Monte Carlo integration error.
Under the null hypothesis, Y is not affected by assignment to or receipt of the active treatment;
it is therefore treated like a covariate in the imputation model. Even in the absence of other
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covariates (X), Y alone may still be successful in stochastically identifying the missing compliance
statuses, thus providing tests of CACE with power over ITT tests (see Section 2.3). When additional
covariates that affect compliance status supplement Y in the imputation model (e.g., in a Bayesian
generalized linear model), the compliance identification tends to sharpen, providing CACE tests
with greater power.
In settings with one-sided non-compliance, only the compliance statuses of units assigned to
the control group are missing. Let ωc be the super-population proportion of compliers, and let
η = (ηc, ηn) be the parameters that govern the outcome distributions of compliers and never-
takers, respectively. Note that under the null hypothesis, these are only two outcome distributions;
units within a compliance stratum have the same outcome distributions, regardless of their treat-
ment assignment. The posterior predictive distribution of the missing compliance statuses can be
obtained using a two-step data augmentation algorithm (Tanner and Wong, 1987). Using the cur-
rent (or initial, if starting the algorithm) values of the parameters, the missing compliance statuses
are drawn according to Bayes’ rule:
P (Ci = c|Y obsi , Xi, Zi = 0, Dobsi = 0, ωc,η) =
ωcgc(Y
obs
i ; ηc)
ωcgc(Y obsi ; ηc) + (1− ωc)gn(Y obsi ; ηn)
, (1)
where gc(y; ηc) and gn(y; ηn) are the outcome probabilities (or densities) of y for compliers and never-
takers, respectively. Once the missing compliance statuses are drawn, new parameter values are
drawn from their compliance-complete-data posterior distributions. These two steps are alternated
until distributional convergence. After convergence, the draws of the missing compliance statuses
can be treated as posterior predictive imputations. Obtaining posterior draws of parameters —
and consequently, posterior predictive draws of the missing compliance statuses — may be more
straightforward if models are conjugate, e.g., Beta-Binomial or Dirichlet-Multinomial models (see
Section 2.3).
For each imputation of the missing compliance statuses, a randomization test (here involving
only one random hypothetical assignment for computational efficiency) is performed in Steps 3–6.
Because p-values are defined as conditional probabilities given that the sharp null hypothesis is
true, the imputation of Y potential outcomes in Step 3 must occur under this hypothesis. Table 3
shows the observed values of the Science table from Table 2, with the Y potential outcomes imputed
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under the sharp null hypothesis of zero treatment effect. For computational efficiency, Step 3 can
be performed just once (before the loop) because this imputation is deterministic.
Assignment D(z) Compliance status Y (z)
Unit Xi Zi Di(0) Di(1) Ci Yi(0) Yi(1)
1 X1 0 0 ? ? Y
obs
1 (Y
obs
1 )
2 X2 1 0 1 c (Y
obs
2 ) Y
obs
2
3 X3 1 0 1 c (Y
obs
3 ) Y
obs
3
4 X4 1 0 0 nt (Y
obs
4 ) Y
obs
4
. . . . . .
N XN 0 0 ? ? Y
obs
N (Y
obs
N )
Table 3: The observed values of the Science table from Table 2, with the missing Y potential
outcomes imputed under the sharp null hypothesis of zero treatment effect. Imputed Y potential
outcomes are in parentheses.
The random draw of a hypothetical assignment vector in Step 4 depends on the specific assign-
ment mechanism used in the experiment, e.g., complete randomization or block randomization. A
seemingly alternative procedure to the one described above switches the order of Steps 2 and 4,
such that the hypothetical assignment vector is drawn first, and the missing compliance statuses
are imputed second. This alternative procedure, however, is exactly equivalent to the one described
above because the imputation of the missing compliance statuses under the null hypothesis is in-
fluenced by Z only through Cobs. Because Cobs is fixed by the actual observed data, reversing the
order of Steps 2 and 4 does not affect the overall inferential procedure. Intuitively, we can consider
the posterior predictive p-value as a double integral over the missing compliance statuses and the
randomization; switching the order of integration does not affect the result.
2.3 Illustrative simulations with non-compliance
Consider this modified example from Rubin (1998): suppose a completely randomized double-blind
experiment is conducted to investigate the effect of a new drug (provided in addition to standard
care) versus standard care alone on Y , which measures the severity of patients’ heart attacks in
the year following treatment. Y is ordinal, taking on values of 0, 1, and 2 (no, mild, and severe
attacks, respectively). We assume that all of the patients survive through the year. We also
assume one-sided non-compliance, so our experiment has two groups of patients: compliers and
never-takers.
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In our simulation, we randomly select N = 1000 units from a super-population of 10% compli-
ers and 90% never-takers; the compliers tend to be healthier than the never-takers. We randomly
assign N/2 = 500 units to control and N/2 units to active treatment, observing only the compliance
statuses of units assigned to active treatment. For each unit, we generate an observed Multino-
mial outcome, Y obsi , according to the specified treatment effect hypothesis. Simulation details are
provided in Appendix A.1.
Using the simulated observed data, we calculate two test statistics: (i) the ITT statistic, and (ii)
the MLE of CACE under the exclusion restriction. We then calculate randomization-based posterior
predictive p-values for both test statistics, as described in Section 2.2, under the null hypothesis of
zero treatment effect. (For the multiple imputation of the missing compliance statuses, we place
conjugate Beta(1, 1) priors on the parameters governing the complier and never-taker outcome
distributions.) To evaluate the frequency characteristics of the posterior predictive p-values, we
run 1,000 replications of the data simulation and p-value procedures. Under the null hypothesis, p-
values for the two statistics both appear valid in terms of type I error; their empirical distributions
are approximately uniform. At the α = .05 level, tests on ITT and CACE reject the null hypothesis
in 4.5% and 4.1% of simulations, respectively. Under the alternative hypothesis, tests based on the
CACE are more powerful (see Figure 1), with tests on ITT and CACE rejecting the null hypothesis
in 16.7% and 25.2% of simulations, respectively, at α = .05. In a general setting, the magnitude
of the power gain from the CACE depends on the proportion of compliers, the magnitude of the
treatment effect, and the α level.
3 Experiments with Multiple Testing
3.1 Randomization-based multiple comparisons adjustments
Suppose we have data from a randomized experiment with J estimands and are interested in testing
whether the active treatment has any non-null effects. The desire for J estimands may result, for
example, from multiple outcomes per unit or from multiple, potentially overlapping subgroups of
units. Brown and Fears (1981) and Westfall and Young (1989) first proposed permutation-based
multiple comparisons adjustments, with the latter showing that such adjustments outperform tradi-
tional (e.g., Bonferroni) adjustments in terms of power. They did not, however, explicitly motivate
10
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Figure 1: Joint distribution of 1,000 posterior predictive p-values for ITT and CACE estimates
under the alternative hypothesis. Tests for CACE are more powerful because p-values for CACE
tend to be lower.
their methods using randomized assignment mechanisms and joint randomization distributions.
Furthermore, they assumed specific models that facilitated the calculation of nominal (unadjusted)
p-values and implicitly assumed completely randomized assignments throughout.
Here we extend their ideas to a fully randomization-based procedure for multiple comparisons
adjustments. In contrast to the aforementioned work, our procedure is connected to — and di-
rectly motivated by — the actual randomized assignment mechanism used in the experiment; in
addition, both the nominal and adjusted p-values in our procedure are randomization-based, so we
do not require any assumptions about the underlying distribution of the data. We calculate fully
randomization-based adjusted p-values as follows:
1. Choose test statistics and calculate their observed values.
Choose test statistics, (T1, . . . , TJ), and calculate (T
obs
1 , . . . , T
obs
J ) on the observed data.
2. Impute missing potential outcomes.
Impute the missing potential outcomes under the sharp null hypothesis.
3. Calculate nominal p-values for the observed test statistics.
For j = 1, . . . , J , calculate the randomization-based p-value for T obsj by repeatedly (i.e., M
′
11
times) (i) drawing a random hypothetical assignment vector according to the assignment mech-
anism, and (ii) calculating the test statistic, T hypj , for the corresponding hypothetical observed
data. The nominal, marginal randomization-based p-value for T obsj (j = 1, . . . , J) equals the
proportion of T hypj values that are as extreme as or more extreme than T
obs
j . Record the
(T hyp1 , . . . , T
hyp
J ) values for use in Step 4.
4. Calculate nominal (marginal) p-values for the hypothetical test statistics.
Using the M ′ sets of (T hyp1 , . . . , T
hyp
J ) values from Step 3, calculate a nominal randomization-
based p-value for each T hypj and record the minimum of the p-values for each of the M
′ sets.
5. Obtain the joint randomization distribution of the nominal p-values.
For large M ′, the repetitions of Step 4 appropriately capture the joint randomization distribution
of the test statistics and thus, of the nominal p-values.
6. Calculate adjusted p-values for the observed test statistics.
The adjusted p-value (Westfall and Young, 1989) for T obsj (j = 1, . . . , J) equals the propor-
tion of hypothetical observed datasets for which the minimum of the J nominal p-values for
(T hyp1 , . . . , T
hyp
J ) is less than or equal to the nominal p-value for T
obs
j .
Steps 4–5 essentially represent a translation, i.e., re-scaling, of hypothetical test statistics —
which may have different scales — into hypothetical p-values, which share a common 0–1 scale.
The procedure described above results in individual adjusted p-values that are corrected for the
FWER but are also directly interpretable on their own.
Equivalently, to determine α-level significance, we can compare each nominal p-value to the
familywise α-level cutoff: the α-th quantile of the minimums recorded in Step 4. The probability
that no type I errors are made (i.e., that we fail to reject all J tests under the null hypothesis)
is equivalent to the probability that all J observed marginal p-values are above the cutoff. This
equals the probability that the minimum of the J observed p-values is above the cutoff, which is
1− α by construction. Thus, the probability of at least one type I error — the FWER — is α, as
desired.
Randomization-adjusted p-values are more powerful than traditional Bonferroni-adjusted p-
values, especially when the correlations among the J test statistics are high, as shown by the
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simulations below. Intuitively, suppose the null hypothesis of zero effects is true and that we have
a large number of uncorrelated test statistics; the probability of at least one type I error is quite
high because of the number of tests being conducted. Now suppose instead that those test statistics
are highly correlated; the probability of at least one type I error is reduced because the tests’ type
I errors are likely to occur simultaneously, i.e., for the same random assignments. In fact, if the
test statistics are perfectly correlated, there is essentially only one test being conducted, so no
multiple comparisons adjustment is needed. Bonferroni adjustments in all of these settings are
the same, simply counting the number of p-values being examined. In contrast, by utilizing the
joint distribution of the nominal p-values, the randomization-based adjustments account for the
correlations among test statistics and are less conservative.
3.2 Illustrative simulations with multiple testing
We follow the experimental setup from Section 2.3, modified to include multiple outcomes but
without non-compliance. Suppose that researchers now want to investigate the effect of the new
drug on three outcomes: Y·1, Y·2, and Y·3 (with the first subscript denoting the participant), which
measure the severity of heart attacks (defined as before) in the first, second, and third year after
treatment, respectively. We assume that all of the patients survive through the third year, and we
would like to see whether the drug has an effect on heart attack severity at any of the three time
points.
To evaluate the frequency characteristics of the adjusted randomization-based p-values, we
simulate 1,000 datasets under both null and alternative hypotheses according to each of three
outcome correlation structures: zero, partial (approximately 0.5), and perfect correlation. The
specific data generation processes are found in in Appendices A.2 and B. The correlations among
Yi1(z), Yi2(z), and Yi3(z) (z = 0, 1) are important; however, for a fixed j, the correlation between
Yij(0) and Yij(1) is inconsequential to the simulation because we only ever observe one of the
potential outcomes.
For each simulated dataset, we calculate fully randomization-based adjusted p-values and decide
whether or not to reject the null hypothesis of zero treatment effects across the three time periods
at α = .05. For comparison, we also decide whether or not to reject the null hypothesis using
Bonferroni-adjusted p-values. Simulation results under both null and alternative hypotheses are
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shown in Table 4. Without sacrificing validity under the null hypothesis, the randomization-based
adjustment displays greater power than the Bonferroni adjustment under the alternative hypothesis,
particularly for scenarios with high correlations among outcomes.
Rejection Rate at α = .05
Null is true Alternative is true
Bonferroni Randomization-Based Bonferroni Randomization-Based
Zero correlation .042 .046 .908 .919
Partial correlation .045 .053 .787 .811
Perfect correlation .024 .045 .557 .720
Table 4: Proportions of multiple testing simulations in which the null hypothesis was rejected,
under various data generation processes. Based on 1,000 replications.
4 Experiments with Both Non-compliance and Multiple Testing
It is natural to merge the analysis methods presented in Sections 2 and 3 — both of which use
the randomized assignment mechanism to aid inference — for experiments involving both non-
compliance and multiple testing. The results are valid familywise tests that are more powerful
from both perspectives: more powerful than both those based on standard ITT statistics and those
using traditional multiple comparison adjustments.
Suppose again that we have data from a randomized experiment with J estimands and that
we are interested in testing whether the active treatment has any non-null effects. However, not
all units comply to their treatment assignments; assume for simplicity that non-compliance is one-
sided. In Section 2, Table 2 displays the observed values of a Science table with two Y potential
outcomes — one observed and one missing — for each unit. Here, Table 5 shows the corresponding
observed values of a Science table with multiple estimands resulting from J = 3 outcomes of
interest. Each unit has six potential outcomes, only three of which are observed; the other three
are missing. Within unit i, we observe the same member of (Yij(0), Yij(1)) for each outcome j, e.g.,
if we observe Yi1(1), then we also observe Yi2(1) and Yi3(1).
In experiments with non-compliance and multiple testing, obtaining valid and more powerful
familywise tests involves (i) calculating (nominal) posterior predictive p-values for CACE according
to the procedure in Section 2, and (ii) calculating adjusted posterior predictive p-values using the
joint randomization distribution of the nominal p-values, according to the procedure in Section
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Assignment D(z) Compliance status Y·1(z) Y·2(z) Y·3(z)
Unit Xi Zi Di(0) Di(1) Ci Yi1(0) Yi1(1) Yi2(0) Yi2(1) Yi3(0) Yi3(1)
1 X1 0 0 ? ? Y
obs
11 ? Y
obs
12 ? Y
obs
13 ?
2 X2 1 0 1 c ? Y
obs
21 ? Y
obs
22 ? Y
obs
23
3 X3 1 0 1 c ? Y
obs
31 ? Y
obs
32 ? Y
obs
33
4 X4 1 0 0 nt ? Y
obs
41 ? Y
obs
42 ? Y
obs
43
. . . . . . . . .
N XN 0 0 ? ? Y
obs
N1 ? Y
obs
N2 ? Y
obs
N3 ?
Table 5: Observed and unobserved values of the Science table from Table 2, now with three outcomes
of interest. Missing (unobserved) data are denoted by question marks.
3. Intuitively, this combined method of analysis is preferable because Steps (i) and (ii) provide
power gains through distinct and unrelated mechanisms, and neither sacrifices validity in terms of
type I error. For the J estimands, we expect each individual (nominal) CACE p-value to be more
powerful than its ITT counterpart based on the arguments in Section 2. Furthermore, given a set
of J nominal p-values, we expect randomization-adjusted p-values using the nominal p-values’ joint
randomization distribution to be more powerful than Bonferroni-adjusted p-values, as argued in
Section 3. Naturally, adjusting more powerful nominal p-values in a more powerful manner results
in adjusted p-values that are doubly advantageous in terms of power. The full procedure is detailed
below:
1. Choose test statistics and calculate their observed values.
Choose test statistics, (T1, . . . , TJ), and calculate (T
obs
1 , . . . , T
obs
J ) on the actual observed data.
for i : 1 to M do
2. Impute missing compliance statuses.
Impute the missing compliance statuses, drawing once from their posterior predictive distri-
bution according to a compliance model that assumes the null hypothesis.
3. Impute missing potential outcomes.
Impute all of the missing (Y1, . . . , YJ) potential outcomes under the sharp null hypothesis.
4. Draw a random hypothetical assignment.
Draw a random hypothetical assignment vector according to the assignment mechanism.
5. Re-observe the data.
Treating the imputed compliance statuses and potential outcomes and the hypothetical as-
signment vector as true, create a corresponding hypothetical observed dataset by masking the
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potential outcomes and compliance statuses that would not have been observed under the
hypothetical assignment.
6. Calculate test statistics on the hypothetical observed data.
Calculate (T1, . . . , TJ) on the hypothetical observed data to obtain (T
hyp
1 , . . . , T
hyp
J ). For
j = 1, . . . , J , record whether T hypj is at least as extreme as T
obs
j .
end for
7. Calculate nominal (marginal) posterior predictive p-values for the observed test
statistics.
For j = 1, . . . , J , the nominal (marginal) posterior predictive p-value for the null hypothesis
with respect to the test statistic Tj equals the proportion of the M imputation-randomization
sets created by Steps 2–6 for which T hypj is as extreme as or more extreme than T
obs
j .
8. Calculate nominal posterior predictive p-values for the hypothetical test statistics
and obtain the joint randomization distribution of the nominal posterior predictive
p-values.
For each of the M imputation-randomization sets, translate the hypothetical test statistics
(T hyp1 , . . . , T
hyp
J ) into hypothetical nominal posterior predictive p-values using proportions similar
to the one described in Step 7. This step is a computationally efficient way of obtaining the
joing distribution of hypothetical test statistics on a common p-value scale, analogous to Steps
4–5 from the procedure in Section 3. Record the minimum of each set of nominal p-values.
9. Calculate adjusted posterior predictive p-values for the observed test statistics.
The adjusted posterior predictive p-value for T obsj (j = 1, . . . , J) equals the proportion of the
M imputation-randomization sets for which the minimum of the J nominal posterior predictive
p-values for (T hyp1 , . . . , T
hyp
J ) is less than or equal to the nominal (marginal) posterior predictive
p-value for T obsj .
Under the null hypothesis, the outcomes Y·1, . . . , Y·J inform the multiple imputation of the
missing compliance statuses. Posterior predictive imputations of the missing compliance statuses
can be generated using a data augmentation algorithm similar to the one described in Section 2,
with Equation 1 modified to use the joint set of J observed outcomes.
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4.1 Illustrative simulations with both non-compliance and multiple testing
Again consider the heart treatment example from Sections 2.3 and 3.2: we would like to see whether
the active treatment has an effect on heart attack severity at any of the three time points after
treatment. In these simulations, we assume one-sided non-compliance, with N = 1000 units ran-
domly sampled from super-populations with 10% and 30% compliers. We also ran simulations with
50% and 70% compliance rates, but almost all of the tests were able to detect treatment effects
under the alternative hypotheses, so the comparison tables were less meaningful. Alternative hy-
potheses 1, 2, and 3, in that order, assume treatment effects of increasing size. The data generation
processes are described in Appendices A.3 and B.
For each simulated dataset, a total of 10 familywise tests are conducted. Five of the tests use the
ITT test statistic: one uses the Bonferroni correction and one uses the randomization-based multiple
comparisons adjustment. The other three ITT tests use multiple comparisons adjustments proposed
as alternatives to the Bonferroni correction, by Holm (1979), Hochberg (1988), and Hommel (1988).
The remaining five tests use the MLE of CACE (under the exclusion restriction) as the test statistic
instead of the ITT test statistic. Table 6 displays proportions of simulations in which the null
hypothesis was rejected, based on 1000 replications.
Under the null hypotheses, all 10 familywise tests appear valid in terms of type I error. The
randomization-based tests have the rejection rates closest to the nominal rejection rates. As ex-
pected, the Bonferroni-adjusted tests are conservative, especially when correlation among outcomes
is high. In such settings, there are, in a sense, fewer possible effects to detect, and randomization-
adjusted rejection rates are much higher relative to their Bonferroni-adjusted counterparts. The
Holm, Hochberg, and Hommel procedures all perform similarly to Bonferroni under the null hy-
potheses.
Under alternative hypotheses, the CACE tests generally have higher power, i.e., higher rejection
rates, than the ITT tests. In addition, the randomization-based tests perform very well, especially
when correlation among outcomes is high. The Bonferroni and Holm tests perform extremely
similarly, while the Hochberg and Hommel tests perform slightly better. The randomization-based
procedure generally outperforms all four of the other procedures. In our simulations, CACE tests
with randomization-based multiple comparisons adjustments have up to 3.3 times the power of
17
Compliance Rate = 0.1 Rejection Rate at α = .05
ITT CACE
Null is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .035 .035 .037 .039 .050 .033 .033 .033 .034 .039
Partial correlation .025 .025 .026 .030 .041 .025 .025 .026 .031 .039
Perfect correlation .012 .012 .047 .047 .049 .008 .008 .032 .032 .033
ITT CACE
Alternative 1 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .161 .161 .167 .169 .189 .209 .209 .217 .226 .228
Partial correlation .113 .113 .118 .123 .154 .179 .179 .189 .196 .228
Perfect correlation .062 .062 .139 .139 .139 .094 .094 .205 .205 .207
ITT CACE
Alternative 2 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .303 .303 .306 .310 .342 .357 .357 .366 .369 .380
Partial correlation .204 .204 .219 .225 .273 .303 .303 .314 .320 .357
Perfect correlation .137 .137 .270 .270 .270 .184 .184 .364 .364 .369
ITT CACE
Alternative 3 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .688 .688 .702 .716 .754 .710 .710 .746 .756 .742
Partial correlation .370 .370 .384 .398 .444 .474 .474 .487 .499 .518
Perfect correlation .297 .297 .465 .465 .471 .357 .357 .565 .565 .570
Compliance Rate = 0.3 Rejection Rate at α = .05
ITT CACE
Null is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .037 .037 .037 .038 .046 .031 .031 .032 .033 .038
Partial correlation .033 .033 .035 .036 .044 .025 .025 .025 .026 .035
Perfect correlation .010 .010 .032 .032 .035 .007 .007 .038 .038 .039
ITT CACE
Alternative 1 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .529 .529 .549 .557 .595 .617 .617 .632 .642 .670
Partial correlation .482 .482 .511 .532 .571 .604 .604 .625 .638 .671
Perfect correlation .309 .309 .492 .492 .497 .420 .420 .606 .606 .611
ITT CACE
Alternative 2 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .907 .907 .914 .914 .923 .969 .969 .978 .979 .981
Partial correlation .859 .859 .868 .872 .891 .946 .946 .960 .963 .968
Perfect correlation .752 .752 .862 .862 .865 .871 .871 .957 .957 .957
ITT CACE
Alternative 3 is true Bonferroni Holm Hochberg Hommel Rand-Based Bonferroni Holm Hochberg Hommel Rand-Based
Zero correlation .993 .993 .995 .996 .996 .999 .999 .999 .999 .999
Partial correlation .984 .984 .986 .987 .990 .997 .997 .998 .999 .999
Perfect correlation .966 .966 .993 .993 .993 .989 .989 .999 .999 .999
Table 6: Proportions of simulations in which the null hypothesis was rejected, under various data
generation processes. Based on 1000 replications.
traditional Bonferroni ITT tests, when treatment effects are difficult to detect. The relative power
gain is less pronounced when treatment effects are larger, though gains are still apparent in the
absolute scale. In a particular experimental setting, the magnitude of the power gain from the
combined analysis method depends on the compliance rate, the magnitude of the treatment effect,
the α level, and the correlation of the multiple test statistics.
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5 The National Job Training Partnership Act Study
Title II of the United States Job Training Partnership Act (JTPA) of 1982 funded employment
training programs for economically disadvantaged residents (Bloom, Orr, Bell, Cave, Doolittle,
Lin, and Bos, 1997; Abadie, Angrist, and Imbens, 2002). To evaluate the effectiveness of those
training programs, the National JTPA Study conducted a randomized experiment through 16
local administration areas involving a total of around 20,000 participants who applied for JTPA
services from November 1987 to September 1989 (W.E. Upjohn Institute for Employment Research,
2013). Treatment group participants were eligible to receive JTPA services, while control group
participants were ineligible to receive JTPA services for 18 months. Not every participant assigned
to the treatment group actually enrolled and received JTPA services.
5.1 The data
Monthly employment outcomes were recorded for 30 months after assignment through follow-up
surveys and administrative records from state unemployment insurance agencies. Researchers were
interested in measuring JTPA effects across three time periods representing various stages of train-
ing and employment: months 1–6 (after assignment), the period when most JTPA enrollees were
in the program; months 7–18, approximately the first post-program year; and months 19–30, ap-
proximately the second post-program year (Bloom, Orr, Bell, Cave, Doolittle, Lin, and Bos, 1997).
Bloom, Orr, Bell, Cave, Doolittle, Lin, and Bos (1997)’s original JTPA report evaluates effects
on average income but does not explicitly address the large portion of zero-income (i.e., unem-
ployed) participants. Although the report describes effects by subperiod as well as by various
participant subgroups, it fails to mention or employ any multiple comparisons adjustments. Here
we focus on JTPA’s effects on employment status and use gender as our only background covariate;
this facilitates standard, non-controversial modeling choices (see Section 5.2) and allows us to high-
light our methodological contributions rather than discuss the sensitivity of our results to various,
possibly complicated modeling decisions. Our methods can be extended to evaluate effects on other
outcome variables, such as income and wages, provided that we outline a reasonable imputation
model (Zhang, Rubin, and Mealli, 2009).
We would like to evaluate whether JTPA had an effect on employment status for any of the three
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time periods. Because employment characteristics often differ by gender, we examine JTPA effects
for the three time periods by gender, for a total of six gender-time groups. For illustrative purposes,
we restrict our study population to adults who had obtained a high school or GED diploma (7,445,
or 66.4%, of the 11,204 total adults in the original JTPA study) and assume complete randomization
(with an approximate 2 : 1 treatment-to-control assignment ratio) of the participants, ignoring the
local administration structure because of the limitations of the available data.
Of the 5,009 participants assigned to the treatment group, 3,316 (66.2%) subsequently received
JTPA training. Although the study protocol barred participants assigned to the control group
from receiving JTPA services for 18 months, 41 (1.7%) of 2,436 adults in the control group did
in fact receive services within that time frame. To create a simpler setting with true one-sided
non-compliance, we discard these 41 participants (0.6% of the 7,445 total adults in our study) with
the belief that their inclusion would have a negligible influence on the resulting inference.
Given two genders and three time periods, we have six complier-focused estimands in total,
each one representing the difference in employment proportions within a particular gender-time
group when receiving versus not receiving JTPA services. Two summaries of the observed data are
provided in Figure 2 and Table 7. Figure 2 shows observed employment proportions across the six
gender-time groups by observed compliance status. Within every group, observed compliers are
employed at a higher rate than observed never-takers. Participants with unobserved compliance
statuses (i.e., those assigned to control) are a mixture of compliers and never-takers, and tend to
be employed at a rate in between the rates for observed compliers and observed never-takers.
Table 7 displays observed employment proportions across the gender-time groups according to
both treatment assignment and treatment receipt, with the corresponding compliance composi-
tions. We see that participants who received JTPA services, all of whom are compliers, tend to
be employed at a higher rate than participants who were merely assigned to the treatment group
(a mixture of compliers and never-takers), corroborating the findings in Figure 2 and suggesting
that CACE statistics may lead to more significant estimated effects. In addition, we observe that
participants who did not receive JTPA services — including any participants assigned to control
as well as the never-takers assigned to JTPA — are employed at a lower rate than just the partici-
pants assigned to control. This inequality is intuitive because the observed never-takers are shown
in Figure 2 to be employed at a lower rate than the assigned control group.
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Figure 2: Observed employment proportions for JTPA participants by compliance status across
the six gender-time groups.
Observed Employment Proportions
Assigned Control Assigned Treatment
Ci ∈ {c, nt}, Zi = 0 Ci ∈ {c, nt}, Zi = 1
Female, Months 1–6 .709 .723
Female, Months 7–18 .767 .800
Female, Months 19–30 .694 .714
Male, Months 1–6 .765 .785
Male, Months 7–18 .798 .789
Male, Months 19–30 .715 .712
Received Control Received Treatment
(Ci ∈ {c, nt}, Zi = 0) or (Ci = nt, Zi = 1) Ci = c, Zi = 1
Female, Months 1–6 .708 .730
Female, Months 7–18 .764 .818
Female, Months 19–30 .677 .743
Male, Months 1–6 .740 .828
Male, Months 7–18 .769 .823
Male, Months 19–30 .683 .753
Table 7: Observed employment proportions across the six gender-time groups according to both
assignment to and receipt of JTPA services.
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5.2 Imputation model for CACE
To test the null hypothesis of zero effects using the CACE statistic specified in Section 2, we must
specify an imputation model for the missing compliance statuses. Let Xi and Yi denote the gender
and the length-3 vector of employment outcomes (across the three time periods) of participant i.
The three elements of Yi are binary, so there are 2
3 = 8 possible values of Yi; we model Y as a
Multinomial random variable with eight categories. Let ωc be the super-population proportion of
compliers, and let η = (ηfc, ηfn, ηmc, ηmn) be the parameters that govern the outcome distributions
of female compliers, female never-takers, male compliers, and male never-takers, respectively. Under
the null hypothesis, these are the only four outcome distributions because we disregard treatment
assignment. We place a conjugate Beta(1,1) prior on ωc and independent conjugate Dirichlet(1)
priors on the four η parameters, where 1 is a length-8 vector of 1’s.
Conditional on η and a participant’s gender and compliance status, the natural outcome dis-
tribution under the null hypothesis is:
Y obsi |Xi = x,Ci = q,η ∼ Multinomial(1, ηxq).
Note that we do not assume that the three employment outcomes are independent; this model is
fully non-parametric for the joint distribution of the three outcomes. The posterior distributions of
ωc and η are informed by the outcomes of the participants with observed compliance statuses, i.e.,
those assigned to active treatment, and remain Beta and Dirichlet, respectively. For each gender x
and compliance status q, write the Multinomial probability vector as
ηxq = (pixq1, ..., pixq7, 1− pixq1 − . . .− pixq7).
Let
gxq(y; ηxq) = pi
I{y=(0,0,0)}
xq1 pi
I{y=(0,0,1)}
xq2 . . . (1− pixq1 − . . .− pixq7)I{y=(1,1,1)}
denote the probability of outcome y for participants of gender x and compliance status q. Then,
given a posterior draw of (ωc,η), the missing compliance statuses are imputed probabilistically
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according to Bayes’ rule:
P (Ci = c|Y obsi , Xi = x, Zi = 0, ωc,η) =
ωcgxc(Y
obs
i ; ηxc)
ωcgxc(Y obsi ; ηxc) + (1− ωc)gxn(Y obsi ; ηxn)
. (2)
5.3 Results and analysis
The observed values of the ITT and CACE statistics — i.e., the estimated effects of JTPA assign-
ment and of receipt, respectively — are shown in the second column of Table 8. As we expect, the
observed CACE values have larger magnitudes; the estimated ITT effects are diluted toward zero by
the never-takers, who do not receive any treatment benefit. Because ITT = ωc∗CACE+(1−ωc)∗0,
the estimated ITT effects are diluted by a proportion equal to one minus the compliance rate. Due
to the random treatment assignment, we expect the overall compliance rate to be approximately
equal to the compliance rate observed in the treatment group (66.2%).
Adjusted p-values
ITT Estimated Effect Nominal p-value Bonferroni Randomization
Female, Months 1–6 .014 .351 1.000 .895
Female, Months 7–18 .020 .199 1.000 .685
Female, Months 19–30 .033 .014 .085 .077
Male, Months 1–6 -.008 .582 1.000 .991
Male, Months 7–18 .020 .175 1.000 .636
Male, Months 19–30 -.003 .874 1.000 1.000
Adjusted p-values
CACE Estimated Effect Nominal p-value Bonferroni Randomization
Female, Months 1–6 .020 .130 .778 .302
Female, Months 7–18 .034 .009 .055 .026
Female, Months 19–30 .049 .0002 .001 .001
Male, Months 1–6 -.010 .462 1.000 .804
Male, Months 7–18 .028 .028 .169 .076
Male, Months 19–30 -.001 .967 1.000 1.000
Table 8: Observed values, nominal p-values, and Bonferroni- and randomization-adjusted p-values
for the six JTPA gender-time groups. Nominal p-values are obtained through randomization tests
using 10,000 randomizations.
Using randomization tests and the methods described in Section 4, we obtain one set of nominal
ITT p-values and a second set of nominal CACE p-values, listed in the third column of Table 8.
Each set contains six p-values, one for each gender-time group. We also apply Bonferroni and
randomization adjustments to both sets of nominal p-values, resulting in four total sets of adjusted
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p-values, listed in the rightmost columns of Table 8.
The nominal ITT p-value for the “Female, Months 19–30” group indicates statistical significance
at the α = .05 level. However, after adjusting for multiple comparisons, neither the Bonferroni-
nor randomization-adjusted ITT p-values for this group meets the .05 threshold. Across the six
gender-time groups, the randomization-adjusted p-values tend to be smaller than their Bonferroni-
adjusted counterparts; the adjusted p-values are tempered less when controlling the FWER via
the statistics’ joint randomization distribution because of the correlations among the six nominal
p-values.
Overall, the CACE p-values are smaller — more sensitive to complier-only effects — than the
ITT p-values. In particular, the CACE p-values for the “Female, Months 7–18” and “Female,
Months 19–30” groups indicate a much greater level of significance for the estimated effects of
JTPA on employment. Applying randomization-based instead of Bonferroni adjustments to the
CACE p-values further increases the indicated significance of these estimated effects. The small
randomization-adjusted CACE p-values for these groups suggest that either an event has occurred
that is a priori rare under the sharp null hypothesis of zero effects, or the sharp null hypothesis is
not true — receipt of JTPA services did have an effect on the employment statuses of females with
high school or GED diplomas in their first and second post-program years. The corresponding ITT
p-values, although smallest among the six groups, are larger and do not have sufficient power to
detect an effect on employment status for any of the gender-time groups.
This increase in power is general. We observe similar p-value trends when comparing our
methods to ITT and Bonferroni analyses on JTPA data without the high school/GED diploma
restriction as well as on other JTPA subgroups analyzed in Bloom, Orr, Bell, Cave, Doolittle, Lin,
and Bos (1997).
6 Conclusion
We have detailed a randomization-based procedure for analyzing experimental data in the presence
of both non-compliance and multiple testing that is more powerful than traditional ITT and Bon-
ferroni analyses. As shown through simulations and analyses of the National JTPA Study data,
a combined randomization-based procedure can be doubly advantageous, offering gains in power
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from both perspectives.
The ITT tests for the JTPA Study suggest that the training program had no real effects in
increasing employment for either gender at any time point. The Bonferroni-adjusted CACE tests
suggest that JTPA only increased employment for females in the long term (months 19–30). From
a policy perspective, this initiative may be deemed too costly based on the time delay, as well as
the fact that all five other subgroups had insignificant effects. Once we look at the randomization-
adjusted CACE tests though, we conclude that JTPA actually had a positive effect on employment
for females as soon as they finish the training program, and that the effect sustained into the longer
term. Thus, it seems reasonable for policymakers to fund similar job training programs targeted
for women.
Westfall and Young (1989) assumed Binomial data that facilitate closed-form calculations of
nominal p-values, which were then adjusted using a permutation test. Here we propose fully
randomization-based p-values – we exploit the randomization test to calculate both nominal and
adjusted p-values. In addition, Westfall and Young (1989) described the adjusted p-values as
“permutation-style,” not explicitly motivated by the assignment mechanism in a randomized ex-
periment. In its exploration of non-compliance, Rubin (1998) required the randomization test to
follow the randomized assignment mechanism actually used in the original experiment, an approach
we advocate.
A number of other multiple comparisons procedures aim to address the false discovery rate
(FDR) (Benjamini and Hochberg, 1995), rather than the FWER. These two error metrics are
conceptually different; the choice of metric should be decided by the researcher depending on the
field and specific research setting and goals. FDR is often preferred in settings with a large number
of tests, such as genetic studies, in which finding one true genetic link may outweigh finding a few
spurious links. In such cases, attempting to make exactly zero type I errors can be quite restrictive.
On the other hand, FWER is often used in social science and pharmaceutical settings, in which
governmental and regulatory agencies place the onus on the researcher to show that the treatment
provides a beneficial effect. In these cases, the number of tests tends to be smaller, and type I
errors can be extremely costly in terms of dollars to taxpayers and health risks (e.g., side effects)
to patients. For these reasons, we focus our discussion on the FWER.
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Appendices
A Marginal Distributions for Simulations
A.1 Non-compliance
For unit i = 1, . . . , N , the control potential outcomes for compliers and never-takers have the
following marginal distributions:
Yi(0)|Ci = c ∼ Multinomial(.45, .45, .10); (3)
Yi(0)|Ci = nt ∼ Multinomial(.02, .02, .96). (4)
Under the null hypothesis, Yi(1) has the same marginal distribution as Yi(0) regardless of compliance
status. Under the alternative hypothesis, the complier treatment potential outcomes follow:
Yi(1)|Ci = c ∼ Multinomial(.80, .10, .10), (5)
while the never-taker treatment potential outcomes follow Equation 4.
A.2 Multiple testing
For unit i = 1, . . . , N and outcome j = 1, 2, 3, the control potential outcomes marginally follow:
Yij(0) ∼ Multinomial(.45, .45, .10). (6)
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Under the null hypothesis, Yij(1) has the same marginal distribution as Yij(0). Under the alternative
hypotheses, the treatment potential outcomes have the following marginal distribution:
Yij(1) ∼ Multinomial(.50, .45, .05). (7)
A.3 Non-compliance and multiple testing
Under the null hypothesis, the potential outcomes follow the marginal distributions described by
Equations 3 and 4 in Appendix A.1. Yi(1) has the same marginal distribution as Yi(0) regardless
of compliance status.
Under alternative hypothesis 1, the complier potential outcomes marginally follow:
Yi(0)|Ci = c ∼ Multinomial(.45, .45, .10); Yi(1)|Ci = c ∼ Multinomial(.80, .10, .10) (8)
Under alternative hypothesis 2, the complier potential outcomes marginally follow:
Yi(0)|Ci = c ∼ Multinomial(.30, .60, .10); Yi(1)|Ci = c ∼ Multinomial(.80, .10, .10) (9)
Under alternative hypothesis 3, the complier potential outcomes marginally follow:
Yi(0)|Ci = c ∼ Multinomial(.25, .55, .20); Yi(1)|Ci = c ∼ Multinomial(.80, .10, .10) (10)
B Correlation Structure Generation
To simulate correlation structures among multiple outcomes, we use the following processes uti-
lizing the marginal distributions described in Appendix A. For units i = 1, . . . , N and treatment
assignment z = 0, 1,
• Zero correlation: all Yij(z) (j = 1, 2, 3) are drawn independently according to their marginal
distributions.
• Partial correlation: Yi1(z) is drawn according to its marginal distribution. With probability
1/2, Yi2(z) is set equal to the drawn value of Yi1(z); otherwise, Yi2(z) is drawn independently
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according to its marginal distribution. Yi3(z) is set equal to Yi1(z) with probability 1/3, set equal
to Yi2(z) with probability 1/3, or drawn independently according to its marginal distribution.
• Perfect correlation: Yi1(z) is drawn according to its marginal distribution. Then both Yi2(z) and
Yi3(z) are set equal to the drawn value of Yi1(z).
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